• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病患者肝功能异常:患病率、临床相关性及潜在病理学。

Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies.

机构信息

Departments of Gastroenterology, Royal Hallamshire Hospital, Sheffield, UK.

出版信息

Diabet Med. 2009 Dec;26(12):1235-41. doi: 10.1111/j.1464-5491.2009.02839.x.

DOI:10.1111/j.1464-5491.2009.02839.x
PMID:20002475
Abstract

AIMS

To determine the prevalence of elevated alanine transaminase (ALT) in a large cohort of patients with Type 1 diabetes and to examine the clinical correlations and causes. Methods Patients with Type 1 diabetes mellitus were prospectively recruited and ALT, glycated haemoglobin and lipid profile were measured. Patients with Type 2 diabetes mellitus were recruited as a comparison group.

PATIENTS

with abnormal ALT were investigated for underlying causes. Prevalence of abnormal ALT was analysed at three separate cut-offs and multivariable analysis used to identify independent risk factors.

RESULTS

Nine hundred and eleven with Type 1 diabetes and 963 with Type 2 diabetes were included. The prevalence of elevated ALT was dependent on the cut-off value: > 30 IU/l in males and > 19 IU/l in females, > 50 and > 63 IU/l was 34.5, 4.3 and 1.9%, respectively, in Type 1 diabetes and 51.4, 8.2 and 3.7%, respectively, in Type 2 diabetes. In Type 1 diabetes an elevated ALT was associated with worse glycaemic control, age > 55 years and elevated triglycerides. Investigation of these patients revealed a cause in 43.6% of patients, predominantly non-alcoholic fatty liver disease (NAFLD).

CONCLUSIONS

Elevated ALT is not uncommon in Type 1 diabetes and is associated with NAFLD-related risk factors. Patients with Type 1 diabetes and elevated ALT should be investigated as significant abnormalities may be found which are amenable to interventions.

摘要

目的

在大型 1 型糖尿病患者队列中确定丙氨酸转氨酶(ALT)升高的患病率,并研究其临床相关性和病因。方法:前瞻性招募 1 型糖尿病患者,检测 ALT、糖化血红蛋白和血脂谱。招募 2 型糖尿病患者作为对照组。对 ALT 异常的患者进行潜在病因检查。分别在三个不同的切点分析异常 ALT 的患病率,并进行多变量分析以确定独立的危险因素。结果:共纳入 911 例 1 型糖尿病患者和 963 例 2 型糖尿病患者。ALT 升高的患病率取决于切点值:男性>30IU/L,女性>19IU/L,1 型糖尿病的患病率分别为 34.5%、4.3%和 1.9%,2 型糖尿病的患病率分别为 51.4%、8.2%和 3.7%。在 1 型糖尿病中,ALT 升高与血糖控制不佳、年龄>55 岁和甘油三酯升高有关。对这些患者进行检查后,发现 43.6%的患者存在病因,主要为非酒精性脂肪性肝病(NAFLD)。结论:1 型糖尿病中 ALT 升高并不少见,与 NAFLD 相关的危险因素有关。1 型糖尿病且 ALT 升高的患者应进行检查,因为可能会发现可干预的显著异常。

相似文献

1
Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies.1 型糖尿病患者肝功能异常:患病率、临床相关性及潜在病理学。
Diabet Med. 2009 Dec;26(12):1235-41. doi: 10.1111/j.1464-5491.2009.02839.x.
2
Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus.约旦2型糖尿病患者肝转氨酶升高的患病率。
Ann Saudi Med. 2010 Jan-Feb;30(1):25-32. doi: 10.4103/0256-4947.59369.
3
Prevalence of abnormal serum liver enzymes in patients with type 2 diabetes mellitus: a cross-sectional study from China.2型糖尿病患者血清肝酶异常的患病率:一项来自中国的横断面研究。
Postgrad Med. 2016 Nov;128(8):770-776. doi: 10.1080/00325481.2016.1242366. Epub 2016 Oct 17.
4
Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.可改变的临床和生活方式因素与新诊断的 2 型糖尿病患者丙氨酸氨基转移酶水平升高相关:来自全国性 DD2 研究的结果。
Diabetes Metab Res Rev. 2014 Nov;30(8):707-15. doi: 10.1002/dmrr.2539.
5
Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus.
QJM. 2006 Dec;99(12):871-6. doi: 10.1093/qjmed/hcl116.
6
Prevalence of elevated alanine aminotransferase levels in adult participants from a community-based study from northern part of India.印度北部一项基于社区的研究中成年参与者中丙氨酸氨基转移酶水平升高的患病率。
Indian J Gastroenterol. 2020 Dec;39(6):608-613. doi: 10.1007/s12664-020-01091-2. Epub 2020 Oct 24.
7
[Serum levels of alanine aminotransferase in Chilean population: analysis of results of the national health survey 2009-2010].[智利人群血清丙氨酸氨基转移酶水平:2009 - 2010年全国健康调查结果分析]
Rev Med Chil. 2013 Jul;141(7):909-16. doi: 10.4067/S0034-98872013000700011.
8
Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers.墨西哥医护人员队列中肥胖、代谢综合征和糖尿病与转氨酶水平升高风险的纵向关联。
J Dig Dis. 2016 May;17(5):304-12. doi: 10.1111/1751-2980.12341.
9
Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.非酒精性脂肪性肝病的流行情况及其对中国代谢综合征患者丙氨酸氨基转移酶的影响。
J Gastroenterol Hepatol. 2011 Apr;26(4):722-30. doi: 10.1111/j.1440-1746.2010.06509.x.
10
Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus.2型糖尿病一级亲属的胰岛素抵抗及丙氨酸氨基转移酶(ALT)水平
Diabetes Metab Syndr. 2011 Jul-Sep;5(3):143-7. doi: 10.1016/j.dsx.2012.02.011. Epub 2012 Mar 29.

引用本文的文献

1
Longitudinal Analysis of Bone Metabolic Markers and Bone Mechanical Properties in STZ-Induced Diabetic Rats.链脲佐菌素诱导的糖尿病大鼠骨代谢标志物与骨力学性能的纵向分析
J Clin Med. 2024 Sep 20;13(18):5595. doi: 10.3390/jcm13185595.
2
Group-informed attentive framework for enhanced diabetes mellitus progression prediction.基于群组信息的注意力机制框架增强糖尿病进程预测
Front Endocrinol (Lausanne). 2024 Jun 24;15:1388103. doi: 10.3389/fendo.2024.1388103. eCollection 2024.
3
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein.
具有受控形貌的聚酯纳米粒子用于经口递药:以胰岛素作为模型蛋白。
ACS Nano. 2024 May 7;18(18):11863-11875. doi: 10.1021/acsnano.4c01027. Epub 2024 Apr 15.
4
Supplementation Restores Normoglycemia, Corrects Dyslipidemia, and Transcriptionally Modulates Pancreatic and Hepatic Gene Expression in Alloxan-Induced Hyperglycemic Rats.补充剂可恢复四氧嘧啶诱导的高血糖大鼠的正常血糖水平,纠正血脂异常,并在转录水平上调节胰腺和肝脏基因表达。
Metabolites. 2023 Apr 4;13(4):516. doi: 10.3390/metabo13040516.
5
Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology.1 型糖尿病中非酒精性脂肪性肝病:患病率和病理生理学。
Front Endocrinol (Lausanne). 2022 Dec 1;13:1031633. doi: 10.3389/fendo.2022.1031633. eCollection 2022.
6
Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy.1型糖尿病相关肝病:非酒精性脂肪性肝病与糖原性肝病的鉴别
Front Pharmacol. 2021 Oct 25;12:768576. doi: 10.3389/fphar.2021.768576. eCollection 2021.
7
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病(NAFLD)在 1 型糖尿病患者中的流行情况:系统评价和荟萃分析。
J Clin Endocrinol Metab. 2020 Dec 1;105(12):3842-53. doi: 10.1210/clinem/dgaa575.
8
Non-Invasive Assessment of Metabolic Adaptation in Paediatric Patients Suffering from Type 1 Diabetes Mellitus.1型糖尿病患儿代谢适应性的无创评估
J Clin Med. 2019 Oct 26;8(11):1797. doi: 10.3390/jcm8111797.
9
Changes in hepatic metabolic profile during the evolution of STZ-induced diabetic rats via an H NMR-based metabonomic investigation.基于~1H NMR 的代谢组学研究 STZ 诱导的糖尿病大鼠在病程进展中肝代谢谱的变化。
Biosci Rep. 2019 Apr 23;39(4). doi: 10.1042/BSR20181379. Print 2019 Apr 30.
10
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes.1 型糖尿病患者的维生素 D 状态与非酒精性脂肪性肝病。
J Endocrinol Invest. 2019 Sep;42(9):1099-1107. doi: 10.1007/s40618-019-01031-8. Epub 2019 Mar 7.